Trials
Search / Trial NCT06437587

Effects of Appropriate Technology for Home-based Rehabilitation in Patients With Post-stroke Physical Dysfunction

Launched by XI CHEN · May 25, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

Home Based Rehabilitation Appropriate Technology

ClinConnect Summary

This clinical trial is studying a new approach called S-HRAT, which aims to help people who have had a stroke regain their movement and improve their daily activities. The focus is on patients who are in the recovery phase, meaning they are between two weeks and six months after their stroke. If you or a loved one is at least 18 years old, has suffered a stroke confirmed by medical imaging like a CT or MRI, and is experiencing difficulties with movement, you may be eligible to participate.

Participants in the trial will engage in home-based rehabilitation activities designed to enhance their motor skills and ability to perform everyday tasks. It's important to know that this study is looking for individuals who are not currently in a hospital or rehabilitation facility, and who do not have serious health issues or a history of mental illness. If you meet these criteria, this trial could be an opportunity to receive support in your recovery journey while contributing to valuable research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age≥18;
  • Patients diagnosed with cerebrovascular disease who have cerebral infarction or cerebral hemorrhage based on cranial CT or MRI and meet the diagnostic criteria;
  • Patients are in the non-acute phase, meaning between two weeks and six months after the onset of the disease;
  • Patients with limb dysfunction.
  • Exclusion Criteria:
  • Return to a hospital or rehabilitation facility after discharge;
  • The patient has a history of mental illness and dyslexia;
  • Patients have a combination of serious, life-threatening conditions.

About Xi Chen

Xi Chen is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, Xi Chen collaborates with leading researchers and healthcare professionals to conduct rigorously designed clinical trials. The organization prioritizes patient safety and ethical standards while striving to deliver meaningful outcomes that address unmet medical needs. Through a robust network and a commitment to scientific excellence, Xi Chen aims to contribute significantly to the advancement of healthcare and improve the lives of patients worldwide.

Locations

Daqing, Heilongjiang, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0